enGene Holdings Inc.
ENGN
$7.18
-$0.07-0.97%
NASDAQ
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.09% | 5.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.01% | 31.84% | |||
| Operating Income | 21.01% | -31.84% | |||
| Income Before Tax | 22.47% | -33.48% | |||
| Income Tax Expenses | -- | -307.95% | |||
| Earnings from Continuing Operations | 21.46% | -30.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.46% | -30.66% | |||
| EBIT | 21.01% | -31.84% | |||
| EBITDA | 21.15% | -31.84% | |||
| EPS Basic | 40.00% | -29.93% | |||
| Normalized Basic EPS | 41.75% | -32.73% | |||
| EPS Diluted | 40.00% | -29.93% | |||
| Normalized Diluted EPS | 41.75% | -32.73% | |||
| Average Basic Shares Outstanding | 30.91% | 0.56% | |||
| Average Diluted Shares Outstanding | 30.91% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||